Home > Income Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Revenue

    Back to Income Statement
WINDLAS BIOTECH is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹904 Cr₹760 Cr₹631 Cr₹513 Cr₹466 Cr

What is the latest Revenue of WINDLAS BIOTECH ?

The latest Revenue ratio of WINDLAS BIOTECH is ₹904 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹904 Cr
Mar2025₹760 Cr
Mar2024₹631 Cr
Mar2023₹513 Cr
Mar2022₹466 Cr

How is Revenue of WINDLAS BIOTECH Trending?

Years Revenue % Change
Mar2026 ₹904 Cr
18.98
Mar2025 ₹760 Cr
20.43
Mar2024 ₹631 Cr
22.97
Mar2023 ₹513 Cr
10.12
Mar2022 ₹466 Cr -

Compare Revenue of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹2,316.2 Cr 13.1% 28.9% 12.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,634.0 Cr -2.9% -2.3% 21.8% Stock Analytics
DIVIS LABORATORIES ₹241,576.0 Cr -1.6% 9.8% 51.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.6% -2.3% 37.5% Stock Analytics
CIPLA ₹111,888.0 Cr -2.2% -6.1% -12.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,322.1 Cr -0.9% -1.8% -9.8% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

13.1%

28.9%

12.5%

SENSEX

-1%

-2.6%

-4.1%


You may also like the below Video Courses